Time interval between Sentinel Lymph Node Biopsy and Excision of Primary Melanoma does not impact long term outcomes in a large UK cohort
Saved in:
| Main Authors: | G. Kounidas, A. Strazda, T. Pasha, A. Roshan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277261182400168X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review of risk prediction tools for primary cutaneous melanoma outcomes and validation of sentinel lymph node positivity prediction in a UK tertiary cohort
by: R. N. Manton, et al.
Published: (2024-11-01) -
Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
by: Marie-Laure Matthey-Giè, et al.
Published: (2013-01-01) -
Role of Sentinel Lymph Node Biopsy in the Management of Merkel Cell Carcinoma
by: Eric P. Arruda, et al.
Published: (2012-01-01) -
Lymph Node Operative Experience in the UK – What’s Changed?
by: O. Jones, et al.
Published: (2024-01-01) -
Comparison between 18F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature
by: Paoletta Mirk, et al.
Published: (2011-01-01)